Supporting Verification and Validation of a Medical Device Software (MDSW)

REPHINE SPEECH MARKS OPEN MEDICALDEVICES

Rephine’s expertise in medical device software verification gave us confidence that our product met MDR requirements from the start. Their structured approach ensured compliance while keeping us on track for timely commercialisation.

Client Testimonial

REPHINE SPEECH MARKS CLOSE MEDICALDEVICES

About this Case Study

A medical device start‑up developing a new Medical Device Software (MDSW) required expert support to ensure full functional verification and compliance with MDR regulatory standards. Although the product had a clear intended use and defined requirements, the client lacked the in‑house experience needed to conduct a compliant verification and validation process independently.

Rephine was engaged to perform a complete verification and validation programme, ensuring the software met regulatory expectations and that all activities, evidence, and documentation aligned with MDR requirements from the outset.

Through a structured approach covering requirements understanding, functional verification, validation support and knowledge transfer, Rephine enabled the client to build strong regulatory readiness and accelerate their path to CE marking.

 

Key outcomes included:

• Full functional verification completed successfully against defined requirements
• Verification strategy accepted by both the Health Authority and Notified Body
• Immediate progression to clinical validation due to the adequacy of the verification approach
• Reduction of project risks and costs by avoiding duplicated verification work
• Direct path to CE Mark approval, significantly shortening time‑to‑market
• Strengthened internal capability through training and knowledge transfer

 

Download the full case study to discover:

• How Rephine aligned technical verification with MDR compliance from the start
• The structured steps taken to ensure “right first time” execution
• The benefits of a robust verification package that enabled smooth transition into clinical validation
• The measurable commercial impact of accelerated regulatory readiness

 

Result: A fully verified and compliant Medical Device Software supported by a strong evidence package, giving the client confidence in their MDR readiness and enabling timely market access.

Supporting Verification and Validation of a Medical Device Software (MDSW

Download the Case Study

View other our other resources and company news

Ensuring Compliance and Data Integrity in Pharmacovigilan Case Study

Driving Global QMS Harmonisation for a Pharmaceutical Company

This case study outlines how Rephine helped a global pharmaceutical group implement and validate a harmonised Quality Management System across more than seventy sites. It ...
Read More
Banner Resource Hub Web Guide

How to Structure MDR Technical Documentation (Annex II & III). A Practical Compliance Guide

This white paper provides a practical guide to structuring MDR Technical Documentation under Annex II and Annex III. It explains how to organise evidence, maintain ...
Read More
CSV Blog

IT Quality Assurance in Regulated Life Sciences: Key Insights

IT Quality Assurance is pivotal in regulated life sciences. From CSV and data integrity to change control and audit readiness, discover how IT QA ensures ...
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan General

Practical compliance and inspection readiness for UK pharmaceutical quality systems

Explore how UK pharmaceutical and biotech organisations can stay prepared for MHRA, EMA and FDA inspections. This session provides expert guidance on inspection trends, compliance ...
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan Case Study

Supporting Verification and Validation of a Medical Device Software (MDSW)

Discover how a medical device start‑up successfully verified and validated its new Medical Device Software in line with MDR requirements. With Rephine’s structured approach to ...
Read More
BANNER Practical Guide to Post Market Surveillance PMS under EU MDR IVDR CSV

Practical Guide to the EMA’s Draft EU GMP Revisions

The EU’s new Product Liability Directive (2024/2853) changes who can be held liable and what damages can be claimed. From software and data loss to ...
Read More
BANNER Practical Guide to Post Market Surveillance PMS under EU MDR IVDR Guide

Practical Guide to Post-Market Surveillance (PMS) under EU MDR/IVDR

The EU’s new Product Liability Directive (2024/2853) changes who can be held liable and what damages can be claimed. From software and data loss to ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

AI for Pharmaceutical SOPs: Transforming Quality Management and Compliance

Rephine helps pharmaceutical and biotech companies transition to digital QMS platforms like Veeva Vault, MasterControl, or TrackWise. From vendor-neutral selection to full GxP-compliant validation and ...
Read More
Ensuring Compliance and Data Integrity in Pharmacovigilan CAPA

Strengthening CAPA & Exceptions Management

Learn how Rephine’s tailored GxP training helped a pharmaceutical manufacturer strengthen CAPA effectiveness, improve compliance, and boost team confidence.
Read More
Contact Us

Strengthen Your Assurance Journey

GMP Chapter 22 Adapting to Hybrid Documentation Standards